| PID | Title | Article | Time | Author | Doi |
|---|---|---|---|---|---|
| 21857920 |
| Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
|---|---|---|---|---|---|---|---|
| ENST00000619920 | PSMC3-213 | 1580 | XM_017018026 | ENSP00000481029 | 439 (aa) | XP_016873515 | P17980 |
| ENST00000531653 | PSMC3-211 | 498 | - | - | - (aa) | - | - |
| ENST00000530887 | PSMC3-208 | 891 | - | ENSP00000437291 | 52 (aa) | - | E9PMW0 |
| ENST00000529500 | PSMC3-206 | 563 | - | - | - (aa) | - | - |
| ENST00000526993 | PSMC3-203 | 580 | - | ENSP00000435141 | 184 (aa) | - | E9PLG2 |
| ENST00000528362 | PSMC3-205 | 546 | - | - | - (aa) | - | - |
| ENST00000602866 | PSMC3-212 | 1373 | - | ENSP00000473652 | 423 (aa) | - | R4GNH3 |
| ENST00000527906 | PSMC3-204 | 604 | - | ENSP00000432103 | 37 (aa) | - | E9PS45 |
| ENST00000530912 | PSMC3-209 | 1390 | - | ENSP00000433097 | 397 (aa) | - | E9PM69 |
| ENST00000298852 | PSMC3-201 | 1544 | - | ENSP00000298852 | 439 (aa) | - | P17980 |
| ENST00000531051 | PSMC3-210 | 777 | - | ENSP00000432970 | 257 (aa) | - | E9PN50 |
| ENST00000530651 | PSMC3-207 | 905 | - | ENSP00000431144 | 301 (aa) | - | E9PMD8 |
| ENST00000524447 | PSMC3-202 | 935 | - | ENSP00000433596 | 311 (aa) | - | E9PKD5 |
| ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
|---|---|---|---|---|---|---|---|---|---|
| ENSG00000165916 | rs10838708 | 11 | 47419962 | G | Height | 23563607 | [NR] | 1.15 | EFO_0004339 |
| ENSG00000165916 | rs2293579 | 11 | 47419207 | A | Serum albumin level | 23022100 | [0.0060-0.0126] unit increase | 0.0093 | EFO_0004535 |
| ENSG00000165916 | rs2293579 | 11 | 47419207 | A | Serum albumin level | 23022100 | [0.0055-0.0117] unit increase | 0.0086 | EFO_0004535 |
| ENSG00000165916 | rs2242511 | 11 | 47420113 | T | Cognitive performance | 30038396 | [0.015-0.031] unit increase | 0.0231 | EFO_0008354 |
| ENSG00000165916 | rs10838708 | 11 | 47419962 | G | Insomnia symptoms (never/rarely vs. usually) | 30804566 | [1.01-1.03] | 1.02 | EFO_0007876 |
| ENSG00000165916 | rs3781627 | 11 | 47419921 | A | Neuroticism | 30643256 | [0.0074-0.0136] unit increase | 0.010487369 | EFO_0007660 |
| ENSG00000165916 | rs3781627 | 11 | 47419921 | A | Depressive symptoms | 30643256 | [0.0047-0.0087] unit increase | 0.006675154 | EFO_0007006 |
| ENSG00000165916 | rs3781627 | 11 | 47419921 | A | Life satisfaction | 30643256 | [0.0059-0.0112] unit increase | 0.00852457 | EFO_0007869 |
| ENSG00000165916 | rs3781627 | 11 | 47419921 | A | Positive affect | 30643256 | [0.0056-0.0104] unit increase | 0.00802266 | EFO_0007869 |

| Ensembl ID | Gene Symbol | Coverage | Identiy | Ortholog | Gene Symbol | Coverage | Identiy | Species |
|---|---|---|---|---|---|---|---|---|
| ENSG00000165916 | PSMC3 | 89 | 41.152 | WBGene00004502 | rpt-2 | 84 | 44.275 | Caenorhabditis_elegans |
| ENSG00000165916 | PSMC3 | 92 | 42.145 | WBGene00004503 | rpt-3 | 92 | 42.145 | Caenorhabditis_elegans |
| ENSG00000165916 | PSMC3 | 75 | 48.684 | WBGene00004501 | rpt-1 | 70 | 48.684 | Caenorhabditis_elegans |
| ENSG00000165916 | PSMC3 | 90 | 45.119 | ENSG00000100764 | PSMC1 | 95 | 61.250 | Homo_sapiens |
| ENSG00000165916 | PSMC3 | 78 | 51.768 | ENSG00000087191 | PSMC5 | 88 | 48.169 | Homo_sapiens |
| ENSG00000165916 | PSMC3 | 75 | 49.013 | ENSG00000161057 | PSMC2 | 76 | 49.013 | Homo_sapiens |
| ENSG00000165916 | PSMC3 | 78 | 46.129 | ENSG00000100519 | PSMC6 | 93 | 46.774 | Homo_sapiens |
| ENSG00000165916 | PSMC3 | 75 | 51.839 | YDL007W | RPT2 | 68 | 51.839 | Saccharomyces_cerevisiae |
| ENSG00000165916 | PSMC3 | 94 | 38.956 | YGL048C | RPT6 | 81 | 47.463 | Saccharomyces_cerevisiae |
| ENSG00000165916 | PSMC3 | 74 | 48.148 | YKL145W | RPT1 | 63 | 48.148 | Saccharomyces_cerevisiae |
| ENSG00000165916 | PSMC3 | 93 | 37.942 | YDR394W | RPT3 | 85 | 38.961 | Saccharomyces_cerevisiae |
| Go ID | Go_term | PubmedID | Evidence | Category |
|---|---|---|---|---|
| GO:0000165 | MAPK cascade | - | TAS | Process |
| GO:0000209 | protein polyubiquitination | - | TAS | Process |
| GO:0000502 | proteasome complex | 17323924. | IDA | Component |
| GO:0000932 | P-body | - | ISS | Component |
| GO:0001824 | blastocyst development | - | IEA | Process |
| GO:0002223 | stimulatory C-type lectin receptor signaling pathway | - | TAS | Process |
| GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | - | TAS | Process |
| GO:0005515 | protein binding | 16763564.19490896.24255178.25416956. | IPI | Function |
| GO:0005524 | ATP binding | - | IEA | Function |
| GO:0005576 | extracellular region | - | TAS | Component |
| GO:0005634 | nucleus | 21630459. | HDA | Component |
| GO:0005634 | nucleus | 2194290. | IDA | Component |
| GO:0005654 | nucleoplasm | - | TAS | Component |
| GO:0005829 | cytosol | - | TAS | Component |
| GO:0006521 | regulation of cellular amino acid metabolic process | - | TAS | Process |
| GO:0008540 | proteasome regulatory particle, base subcomplex | 21873635. | IBA | Component |
| GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | - | TAS | Process |
| GO:0016020 | membrane | 19946888. | HDA | Component |
| GO:0016032 | viral process | - | IEA | Process |
| GO:0016579 | protein deubiquitination | - | TAS | Process |
| GO:0016887 | ATPase activity | 1429620. | ISS | Function |
| GO:0022624 | proteasome accessory complex | - | ISS | Component |
| GO:0031145 | anaphase-promoting complex-dependent catabolic process | - | TAS | Process |
| GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | - | TAS | Process |
| GO:0033209 | tumor necrosis factor-mediated signaling pathway | - | TAS | Process |
| GO:0034774 | secretory granule lumen | - | TAS | Component |
| GO:0036402 | proteasome-activating ATPase activity | - | IEA | Function |
| GO:0038061 | NIK/NF-kappaB signaling | - | TAS | Process |
| GO:0038095 | Fc-epsilon receptor signaling pathway | - | TAS | Process |
| GO:0042802 | identical protein binding | 25416956. | IPI | Function |
| GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | - | TAS | Process |
| GO:0043312 | neutrophil degranulation | - | TAS | Process |
| GO:0043488 | regulation of mRNA stability | - | TAS | Process |
| GO:0043687 | post-translational protein modification | - | TAS | Process |
| GO:0043921 | modulation by host of viral transcription | 2194290.8419915. | IDA | Process |
| GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly | 21873635. | IBA | Process |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 19853614. | IDA | Process |
| GO:0050852 | T cell receptor signaling pathway | - | TAS | Process |
| GO:0055085 | transmembrane transport | - | TAS | Process |
| GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | - | TAS | Process |
| GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | - | TAS | Process |
| GO:0070498 | interleukin-1-mediated signaling pathway | - | TAS | Process |
| GO:0090090 | negative regulation of canonical Wnt signaling pathway | - | TAS | Process |
| GO:0090263 | positive regulation of canonical Wnt signaling pathway | - | TAS | Process |
| GO:1901800 | positive regulation of proteasomal protein catabolic process | - | IEA | Process |
| GO:1901990 | regulation of mitotic cell cycle phase transition | - | TAS | Process |
| GO:1902036 | regulation of hematopoietic stem cell differentiation | - | TAS | Process |
| GO:1904813 | ficolin-1-rich granule lumen | - | TAS | Component |